PhD Scientist with 10+ years of
hands-on research proficiency in the
fields of small molecule drug
discovery and preclinical biomarkers,
conducting in vivo and in vitro
translational studies in the field of
cancer biology, with specific focus on
hematology, blood malignancies, and
therapeutics. <br> I have
successfully authored several grant
proposals (NJ Department of Health,
American Society of Hematology, WES
leukemia society), top-notch
scientific papers (7 peer-reviewed
scientific articles and counting),
technical reports (international
patent deposit for anti-leukemic small
inhibitors), and presented my results
to world-renowned experts during
national and international meetings
(Outstanding Abstract Award -
Federation of American Societies for
Experimental Biology among the
others). In a nutshell: Oncology
scientist with proficiency in drug
discovery, pre-clinical discovery,
target validation, epigenetics.
Expert in in vivo/in vitro disease and
mechanistic modeling, with focus on
T-cell and myeloid leukemias
therapeutics. In vivo modeling of
tumor generation, bone marrow
transplants, PDXs, in vivo treatment,
tissue sampling, necroscopy. Gene
editing expertise via viral and RNP
gene transduction, RNAi, gene
overexpression, gene silencing,
CRISPR/Cas9. Expertness in
cell-based techniques, primary human
samples isolation, cell culturing,
aseptic techniques, drug testing.
NGS assays (RNA-Seq, scRNA-Seq,
ChIP-Seq), RNA assays (qPCR), DNA
assays (PCR, ChIP), Protein assays
(IP, WB), Flow cytometry. Critical
thinker capable in managing complex
scientific programs with excellent
track record of scientific
achievements.